Key Events This Week
3 Aug: Technical momentum shifts amid sideways trend
6 Aug: Downgrade to Sell rating amid technical weakness and valuation concerns
6 Aug: Technical momentum shifts to mildly bearish despite price gains
7 Aug: Week closes at Rs.134.40 (+0.71%)
When is the next results date for Gujarat Kidney & Super Speciality Ltd?
2026-08-07 23:21:50The next results date for Gujarat Kidney & Super Speciality Ltd is scheduled for 14 August 2026....
Read full news article
Gujarat Kidney & Super Speciality Ltd Downgraded to Sell Amid Technical Weakness and Valuation Concerns
2026-08-06 08:35:58Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has seen its investment rating downgraded from Hold to Sell as of 5 August 2026. This change reflects a complex interplay of technical deterioration, valuation concerns, and mixed financial trends despite strong recent profit growth. The company’s Mojo Score now stands at 47.0, with a Mojo Grade of Sell, signalling caution for investors amid evolving market dynamics.
Read full news article
Gujarat Kidney & Super Speciality Ltd Sees Technical Momentum Shift Amid Mixed Signals
2026-08-06 08:06:41Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent 3.29% gain in daily price, key technical indicators such as the MACD, RSI, and moving averages reveal a complex picture that investors must carefully analyse amid the stock’s strong year-to-date returns.
Read full news article
Gujarat Kidney & Super Speciality Ltd Technical Momentum Shifts Amid Sideways Trend
2026-08-03 08:04:05Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. This transition is underscored by a complex interplay of technical indicators including MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced market sentiment despite the stock’s year-to-date outperformance against the Sensex.
Read full news article
Gujarat Kidney & Super Speciality Ltd is Rated Hold
2026-08-01 10:10:49Gujarat Kidney & Super Speciality Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 09 July 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 01 August 2026, providing investors with the most up-to-date insight into its performance and outlook.
Read full news article
Gujarat Kidney & Super Speciality Ltd is Rated Hold
2026-07-21 10:10:04Gujarat Kidney & Super Speciality Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 09 July 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 21 July 2026, providing investors with the most up-to-date view of its fundamentals, returns, and market standing.
Read full news article
Gujarat Kidney & Super Speciality Ltd Shows Technical Momentum Shift Amid Micro-Cap Hospital Sector
2026-07-14 08:07:13Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has witnessed a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by a series of technical indicator signals and price action that suggest improving investor sentiment and potential for further gains.
Read full news article
Gujarat Kidney & Super Speciality Ltd Upgraded to Hold on Improved Technicals and Financials
2026-07-10 08:19:50Gujarat Kidney & Super Speciality Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a marked improvement in technical indicators and solid financial performance. The company’s Mojo Score rose to 52.0, signalling a more balanced outlook amid a micro-cap hospital sector environment. This upgrade follows a comprehensive reassessment across quality, valuation, financial trends, and technical parameters, highlighting both opportunities and challenges for investors.
Read full news article





